Advertisement

International Urology and Nephrology

, Volume 51, Issue 12, pp 2285–2294 | Cite as

Metabolic syndrome is a predictor of decreased renal function among community-dwelling middle-aged and elderly Japanese

  • Ryuichi KawamotoEmail author
  • Taichi Akase
  • Daisuke Ninomiya
  • Teru Kumagi
  • Asuka Kikuchi
Nephrology - Original Paper
  • 38 Downloads

Abstract

Purpose

Metabolic syndrome (MetS) is increasing worldwide with the continuous increase in obesity prevalence. Chronic kidney disease (CKD) is also a major public health problem, but there is controversy over whether baseline MetS is a predictor of decreased renal function among Japanese community-dwelling middle-aged and elderly Japanese.

Methods

We conducted a prospective cohort study designed as part of the Nomura study. We recruited a random sample of 410 men aged 68 ± 8 (mean ± standard deviation; range, 50–95) years and 549 women aged 69 ± 7 (50–84) years during their annual health examination in a single community. We examined the relationship between baseline MetS and renal dysfunction after a 3-year evaluation based on estimated glomerular filtration rate (eGFRCKDEPI) using the CKD-EPI equations modified by the Japan coefficient. CKD was defined as dipstick-positive proteinuria (> or = 1 +) or a low eGFRCKDEPI (< 60 mL/min/1.73 m2).

Results

Of the 959 participants, 413 (43.1%) had MetS at baseline. Annual eGFR decline rate was significantly greater in those with MetS than in those without MetS, and the annual eGFR decline rate of < − 1.2 mL/min/1.73 m2/year increased significantly in relation to presence of baseline MetS, especially low HDL cholesterol (HDL-C). Moreover, the incidence rate of CKD after 3 years was 13.5% and increased significantly in relation to presence of baseline MetS, especially its components such as elevated HbA1c. The multivariate-adjusted odd ratio (OR) for CKD in participants with MetS versus those without MetS was 1.55 (0.99–2.43). The multivariate-adjusted ORs for rapid annual eGFR decline rate were significantly high in patients aged ≥ 65 years and presence of medication, regardless of gender and eGFR value.

Conclusions

Low HDL-C and elevated HbA1c levels correlated significantly with eGFR decline in a short period of 3 years. MetS also showed a significant association with eGFR decline. This study suggests the importance of low HDL-C and elevated HbA1c in the effect of MetS on eGFR decline rather than obesity among Japanese community-dwelling middle-aged and elderly Japanese without CKD.

Keywords

Metabolic syndrome eGFRCKDEPI Decline rate Chronic kidney disease 

Notes

Acknowledgements

This work was supported in part by a grant-in-aid for Scientific Research from the Foundation for Development of Community (2019).

Author contributions

RK participated in the design of the study, performed the statistical analysis, and drafted the manuscript. RK, TA, DN, TK, and AK, contributed to the acquisition and interpretation of data. RK, DN, and AK contributed to the conception and design of the statistical analysis. All authors read and approved the manuscript.

Compliance with ethical standards

Conflict of interest

The authors declare that they have no competing interests.

Ethical approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional research committee at which the studies conducted (IRB Approval Number: 1402009).

Informed consent

We obtained consent through an opt-out procedure from all individual participants included in the study.

Supplementary material

11255_2019_2320_MOESM1_ESM.docx (13 kb)
Supplementary material 1 (DOCX 13 kb)

References

  1. 1.
    Wang J, Ruotsalainen S, Moilanen L, Lepisto P, Laakso M, Kuusisto J (2007) The metabolic syndrome predicts cardiovascular mortality: a 13-year follow-up study in elderly non-diabetic Finns. Eur Heart J 28(7):857–864CrossRefGoogle Scholar
  2. 2.
    Mottillo S, Filion KB, Genest J, Joseph L, Pilote L, Poirier P, Rinfret S, Schiffrin EL, Eisenberg MJ (2010) The metabolic syndrome and cardiovascular risk a systematic review and meta-analysis. J Am Coll Cardiol 56(14):1113–1132CrossRefGoogle Scholar
  3. 3.
    Li X, Li X, Lin H, Fu X, Lin W, Li M, Zeng X, Gao Q (2017) Metabolic syndrome and stroke: a meta-analysis of prospective cohort studies. J Clin Neurosci 40:34–38CrossRefGoogle Scholar
  4. 4.
    Lorenzo C, Okoloise M, Williams K, Stern MP, Haffner SM (2003) The metabolic syndrome as predictor of type 2 diabetes: the San Antonio heart study. Diabetes Care 26(11):3153–3159CrossRefGoogle Scholar
  5. 5.
    Hanley AJ, Karter AJ, Williams K, Festa A, D’Agostino RB Jr, Wagenknecht LE, Haffner SM (2005) Prediction of type 2 diabetes mellitus with alternative definitions of the metabolic syndrome: The Insulin Resistance Atherosclerosis Study. Circulation 112(24):3713–3721CrossRefGoogle Scholar
  6. 6.
    Li W, Wang D, Wang X, Gong Y, Cao S, Yin X, Zhuang X, Shi W, Wang Z, Lu Z (2019) The association of metabolic syndrome components and diabetes mellitus: evidence from China National Stroke Screening and Prevention Project. BMC Public Health 19(1):192CrossRefGoogle Scholar
  7. 7.
    Guembe MJ, Toledo E, Barba J, Martinez-Vila E, Gonzalez-Diego P, Irimia P, Diez J, Vines JJ (2010) Association between metabolic syndrome or its components and asymptomatic cardiovascular disease in the RIVANA-study. Atherosclerosis 211(2):612–617CrossRefGoogle Scholar
  8. 8.
    Levey AS, Eckardt KU, Tsukamoto Y, Levin A, Coresh J, Rossert J, De Zeeuw D, Hostetter TH, Lameire N, Eknoyan G (2005) Definition and classification of chronic kidney disease: a position statement from kidney disease: improving global outcomes (KDIGO). Kidney Int 67(6):2089–2100CrossRefGoogle Scholar
  9. 9.
    Imai E, Horio M, Watanabe T, Iseki K, Yamagata K, Hara S, Ura N, Kiyohara Y, Moriyama T, Ando Y et al (2009) Prevalence of chronic kidney disease in the Japanese general population. Clin Exp Nephrol 13(6):621–630CrossRefGoogle Scholar
  10. 10.
    Nestel P, Lyu R, Low LP, Sheu WH, Nitiyanant W, Saito I, Tan CE (2007) Metabolic syndrome: recent prevalence in East and Southeast Asian populations. Asia Pac J Clin Nutr 16(2):362–367PubMedGoogle Scholar
  11. 11.
    Mills KT, Xu Y, Zhang W, Bundy JD, Chen CS, Kelly TN, Chen J, He J (2015) A systematic analysis of worldwide population-based data on the global burden of chronic kidney disease in 2010. Kidney Int 88(5):950–957CrossRefGoogle Scholar
  12. 12.
    Jiang L, Huang W, Liang Y, Wang F, Duan X, Yang X, Wen J, Wang N (2013) Metabolic syndrome, C-reactive protein and microalbuminuria in a rural Chinese population: a cross-sectional study. BMC Nephrol 14:118CrossRefGoogle Scholar
  13. 13.
    Li XH, Lin HY, Wang SH, Guan LY, Wang YB (2016) Association of microalbuminuria with metabolic syndrome among aged population. Biomed Res Int 2016:9241278PubMedPubMedCentralGoogle Scholar
  14. 14.
    Rashidbeygi E, Safabakhsh M, Delshad Aghdam S, Mohammed SH, Alizadeh S (2019) Metabolic syndrome and its components are related to a higher risk for albuminuria and proteinuria: evidence from a meta-analysis on 10,603,067 subjects from 57 studies. Diabetes Metab Syndr 13(1):830–843CrossRefGoogle Scholar
  15. 15.
    Singh AK, Kari JA (2013) Metabolic syndrome and chronic kidney disease. Curr Opin Nephrol Hypertens 22(2):198–203CrossRefGoogle Scholar
  16. 16.
    Chen J, Kong X, Jia X, Li W, Wang Z, Cui M, Xu D (2017) Association between metabolic syndrome and chronic kidney disease in a Chinese urban population. Clin Chim Acta 470:103–108CrossRefGoogle Scholar
  17. 17.
    Kurella M, Lo JC, Chertow GM (2005) Metabolic syndrome and the risk for chronic kidney disease among nondiabetic adults. J Am Soc Nephrol 16(7):2134–2140CrossRefGoogle Scholar
  18. 18.
    Tozawa M, Iseki C, Tokashiki K, Chinen S, Kohagura K, Kinjo K, Takishita S, Iseki K (2007) Metabolic syndrome and risk of developing chronic kidney disease in Japanese adults. Hypertens Res 30(10):937–943CrossRefGoogle Scholar
  19. 19.
    Kang YU, Kim HY, Choi JS, Kim CS, Bae EH, Ma SK, Kim SW (2014) Metabolic syndrome and chronic kidney disease in an adult Korean population: results from the Korean National Health Screening. PLoS One 9(5):e93795CrossRefGoogle Scholar
  20. 20.
    Kitiyakara C, Yamwong S, Cheepudomwit S, Domrongkitchaiporn S, Unkurapinun N, Pakpeankitvatana V, Sritara P (2007) The metabolic syndrome and chronic kidney disease in a Southeast Asian cohort. Kidney Int 71(7):693–700CrossRefGoogle Scholar
  21. 21.
    (2013) Chapter 2: definition, identification, and prediction of CKD progression. Kidney Int Suppl (2011) 3(1):63–72Google Scholar
  22. 22.
    Kahn R, Buse J, Ferrannini E, Stern M (2005) The metabolic syndrome: time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 28(9):2289–2304CrossRefGoogle Scholar
  23. 23.
    Hu H, Kurotani K, Sasaki N, Murakami T, Shimizu C, Shimizu M, Nakagawa T, Honda T, Yamamoto S, Okazaki H et al (2016) Optimal waist circumference cut-off points and ability of different metabolic syndrome criteria for predicting diabetes in Japanese men and women: Japan epidemiology collaboration on occupational health study. BMC Public Health 16:220CrossRefGoogle Scholar
  24. 24.
    Nair M, Prabhakaran D, Narayan KM, Sinha R, Lakshmy R, Devasenapathy N, Daniel CR, Gupta R, George PS, Mathew A et al (2011) HbA(1c) values for defining diabetes and impaired fasting glucose in Asian Indians. Prim Care Diabetes 5(2):95–102CrossRefGoogle Scholar
  25. 25.
    Yang T, Chu CH, Hsu CH, Hsieh PC, Chung TC, Bai CH, You SL, Hwang LC, Lin CM, Sun CA (2012) Impact of metabolic syndrome on the incidence of chronic kidney disease: a Chinese cohort study. Nephrology (Carlton, Vic) 17(6):532–538CrossRefGoogle Scholar
  26. 26.
    Thomas G, Sehgal AR, Kashyap SR, Srinivas TR, Kirwan JP, Navaneethan SD (2011) Metabolic syndrome and kidney disease: a systematic review and meta-analysis. Clin J Am Soc Nephrol 6(10):2364–2373CrossRefGoogle Scholar
  27. 27.
    Fox CS, Larson MG, Leip EP, Culleton B, Wilson PW, Levy D (2004) Predictors of new-onset kidney disease in a community-based population. JAMA 291(7):844–850CrossRefGoogle Scholar
  28. 28.
    Gelber RP, Kurth T, Kausz AT, Manson JE, Buring JE, Levey AS, Gaziano JM (2005) Association between body mass index and CKD in apparently healthy men. Am J Kidney Dis 46(5):871–880CrossRefGoogle Scholar
  29. 29.
    Garofalo C, Borrelli S, Minutolo R, Chiodini P, De Nicola L, Conte G (2017) A systematic review and meta-analysis suggests obesity predicts onset of chronic kidney disease in the general population. Kidney Int 91(5):1224–1235CrossRefGoogle Scholar
  30. 30.
    Kim YJ, Hwang SD, Oh TJ, Kim KM, Jang HC, Kimm H, Kim HC, Jee SH, Lim S (2017) Association between obesity and chronic kidney disease, defined by both glomerular filtration rate and albuminuria, in Korean adults. Metab Syndr Relat Disord 15(8):416–422CrossRefGoogle Scholar
  31. 31.
    Elsayed EF, Sarnak MJ, Tighiouart H, Griffith JL, Kurth T, Salem DN, Levey AS, Weiner DE (2008) Waist-to-hip ratio, body mass index, and subsequent kidney disease and death. Am J Kidney Dis 52(1):29–38CrossRefGoogle Scholar
  32. 32.
    Trirogoff ML, Shintani A, Himmelfarb J, Ikizler TA (2007) Body mass index and fat mass are the primary correlates of insulin resistance in nondiabetic stage 3-4 chronic kidney disease patients. Am J Clin Nutr 86(6):1642–1648CrossRefGoogle Scholar
  33. 33.
    Visser M, Bouter LM, McQuillan GM, Wener MH, Harris TB (1999) Elevated C-reactive protein levels in overweight and obese adults. JAMA 282(22):2131–2135CrossRefGoogle Scholar
  34. 34.
    Khaodhiar L, Ling PR, Blackburn GL, Bistrian BR (2004) Serum levels of interleukin-6 and C-reactive protein correlate with body mass index across the broad range of obesity. JPEN J Parenter Enter Nutr 28(6):410–415CrossRefGoogle Scholar
  35. 35.
    Urakawa H, Katsuki A, Sumida Y, Gabazza EC, Murashima S, Morioka K, Maruyama N, Kitagawa N, Tanaka T, Hori Y et al (2003) Oxidative stress is associated with adiposity and insulin resistance in men. J Clin Endocrinol Metab 88(10):4673–4676CrossRefGoogle Scholar
  36. 36.
    Engeli S, Gorzelniak K, Kreutz R, Runkel N, Distler A, Sharma AM (1999) Co-expression of renin-angiotensin system genes in human adipose tissue. J Hypertens 17(4):555–560CrossRefGoogle Scholar
  37. 37.
    Masuo K, Mikami H, Itoh M, Ogihara T, Tuck ML (2000) Sympathetic activity and body mass index contribute to blood pressure levels. Hypertens Res 23(4):303–310CrossRefGoogle Scholar
  38. 38.
    Wu SH, Liu Z, Ho SC (2010) Metabolic syndrome and all-cause mortality: a meta-analysis of prospective cohort studies. Eur J Epidemiol 25(6):375–384CrossRefGoogle Scholar
  39. 39.
    Froissart M, Rossert J, Jacquot C, Paillard M, Houillier P (2005) Predictive performance of the modification of diet in renal disease and Cockcroft-Gault equations for estimating renal function. J Am Soc Nephrol 16(3):763–773CrossRefGoogle Scholar

Copyright information

© Springer Nature B.V. 2019

Authors and Affiliations

  1. 1.Department of Community MedicineEhime University Graduate School of MedicineToon-cityJapan
  2. 2.Department of Internal MedicineSeiyo Municipal Nomura HospitalSeiyo-city, EhimeJapan

Personalised recommendations